The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Viral Detection-Global Market Insights and Sales Trends 2024
Synopsis
The global Viral Detection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Viral Detection in various end use industries. The expanding demands from the Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products and Tissue & Tissue Products, are propelling Viral Detection market. Plaque Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCR segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Viral Detection market, driven by demand from China, the second largest economy with some signs of stabilising, the Viral Detection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Detection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Detection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Detection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Detection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Detection covered in this report include Avance Biosciences Inc (US), BSL BIOSERVICE (Germany), Clean Cells (France), Charles River Laboratories International, Inc (US), Lonza Group (Switzerland), Merck KGaA (Germany), Sigma-Aldrich Corporation (US), SGS S.A. (Switzerland) and Texcell, Inc. (France), etc.
The global Viral Detection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Avance Biosciences Inc (US)
BSL BIOSERVICE (Germany)
Clean Cells (France)
Charles River Laboratories International, Inc (US)
Lonza Group (Switzerland)
Merck KGaA (Germany)
Sigma-Aldrich Corporation (US)
SGS S.A. (Switzerland)
Texcell, Inc. (France)
WuXi PharmaTech (Cayman) Inc. (China)
Global Viral Detection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Detection market, Segment by Type:
Plaque Assays
PCR
ELISA
Others
Global Viral Detection market, by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Detection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Viral Detection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Viral Detection in various end use industries. The expanding demands from the Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products and Tissue & Tissue Products, are propelling Viral Detection market. Plaque Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCR segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Viral Detection market, driven by demand from China, the second largest economy with some signs of stabilising, the Viral Detection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Detection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Detection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Detection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Detection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Detection covered in this report include Avance Biosciences Inc (US), BSL BIOSERVICE (Germany), Clean Cells (France), Charles River Laboratories International, Inc (US), Lonza Group (Switzerland), Merck KGaA (Germany), Sigma-Aldrich Corporation (US), SGS S.A. (Switzerland) and Texcell, Inc. (France), etc.
The global Viral Detection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Avance Biosciences Inc (US)
BSL BIOSERVICE (Germany)
Clean Cells (France)
Charles River Laboratories International, Inc (US)
Lonza Group (Switzerland)
Merck KGaA (Germany)
Sigma-Aldrich Corporation (US)
SGS S.A. (Switzerland)
Texcell, Inc. (France)
WuXi PharmaTech (Cayman) Inc. (China)
Global Viral Detection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Detection market, Segment by Type:
Plaque Assays
PCR
ELISA
Others
Global Viral Detection market, by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Detection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Viral Detection
1.1 Viral Detection Market Overview
1.1.1 Viral Detection Product Scope
1.1.2 Viral Detection Market Status and Outlook
1.2 Global Viral Detection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Detection Market Size by Region (2018-2029)
1.4 Global Viral Detection Historic Market Size by Region (2018-2023)
1.5 Global Viral Detection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Detection Market Size (2018-2029)
1.6.1 North America Viral Detection Market Size (2018-2029)
1.6.2 Europe Viral Detection Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Detection Market Size (2018-2029)
1.6.4 Latin America Viral Detection Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Detection Market Size (2018-2029)
2 Viral Detection Market by Type
2.1 Introduction
2.1.1 Plaque Assays
2.1.2 PCR
2.1.3 ELISA
2.1.4 Others
2.2 Global Viral Detection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Detection Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Detection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Detection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Detection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Detection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Detection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Detection Revenue Breakdown by Type (2018-2029)
3 Viral Detection Market Overview by Application
3.1 Introduction
3.1.1 Blood & Blood Products
3.1.2 Cellular & Gene Therapy Products
3.1.3 Stem Cell Products
3.1.4 Tissue & Tissue Products
3.1.5 Vaccines and Therapeutics
3.2 Global Viral Detection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Detection Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Detection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Detection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Detection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Detection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Detection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Detection Revenue Breakdown by Application (2018-2029)
4 Viral Detection Competition Analysis by Players
4.1 Global Viral Detection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Detection as of 2022)
4.3 Date of Key Players Enter into Viral Detection Market
4.4 Global Top Players Viral Detection Headquarters and Area Served
4.5 Key Players Viral Detection Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Detection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Avance Biosciences Inc (US)
5.1.1 Avance Biosciences Inc (US) Profile
5.1.2 Avance Biosciences Inc (US) Main Business
5.1.3 Avance Biosciences Inc (US) Viral Detection Products, Services and Solutions
5.1.4 Avance Biosciences Inc (US) Viral Detection Revenue (US$ Million) & (2018-2023)
5.1.5 Avance Biosciences Inc (US) Recent Developments
5.2 BSL BIOSERVICE (Germany)
5.2.1 BSL BIOSERVICE (Germany) Profile
5.2.2 BSL BIOSERVICE (Germany) Main Business
5.2.3 BSL BIOSERVICE (Germany) Viral Detection Products, Services and Solutions
5.2.4 BSL BIOSERVICE (Germany) Viral Detection Revenue (US$ Million) & (2018-2023)
5.2.5 BSL BIOSERVICE (Germany) Recent Developments
5.3 Clean Cells (France)
5.3.1 Clean Cells (France) Profile
5.3.2 Clean Cells (France) Main Business
5.3.3 Clean Cells (France) Viral Detection Products, Services and Solutions
5.3.4 Clean Cells (France) Viral Detection Revenue (US$ Million) & (2018-2023)
5.3.5 Charles River Laboratories International, Inc (US) Recent Developments
5.4 Charles River Laboratories International, Inc (US)
5.4.1 Charles River Laboratories International, Inc (US) Profile
5.4.2 Charles River Laboratories International, Inc (US) Main Business
5.4.3 Charles River Laboratories International, Inc (US) Viral Detection Products, Services and Solutions
5.4.4 Charles River Laboratories International, Inc (US) Viral Detection Revenue (US$ Million) & (2018-2023)
5.4.5 Charles River Laboratories International, Inc (US) Recent Developments
5.5 Lonza Group (Switzerland)
5.5.1 Lonza Group (Switzerland) Profile
5.5.2 Lonza Group (Switzerland) Main Business
5.5.3 Lonza Group (Switzerland) Viral Detection Products, Services and Solutions
5.5.4 Lonza Group (Switzerland) Viral Detection Revenue (US$ Million) & (2018-2023)
5.5.5 Lonza Group (Switzerland) Recent Developments
5.6 Merck KGaA (Germany)
5.6.1 Merck KGaA (Germany) Profile
5.6.2 Merck KGaA (Germany) Main Business
5.6.3 Merck KGaA (Germany) Viral Detection Products, Services and Solutions
5.6.4 Merck KGaA (Germany) Viral Detection Revenue (US$ Million) & (2018-2023)
5.6.5 Merck KGaA (Germany) Recent Developments
5.7 Sigma-Aldrich Corporation (US)
5.7.1 Sigma-Aldrich Corporation (US) Profile
5.7.2 Sigma-Aldrich Corporation (US) Main Business
5.7.3 Sigma-Aldrich Corporation (US) Viral Detection Products, Services and Solutions
5.7.4 Sigma-Aldrich Corporation (US) Viral Detection Revenue (US$ Million) & (2018-2023)
5.7.5 Sigma-Aldrich Corporation (US) Recent Developments
5.8 SGS S.A. (Switzerland)
5.8.1 SGS S.A. (Switzerland) Profile
5.8.2 SGS S.A. (Switzerland) Main Business
5.8.3 SGS S.A. (Switzerland) Viral Detection Products, Services and Solutions
5.8.4 SGS S.A. (Switzerland) Viral Detection Revenue (US$ Million) & (2018-2023)
5.8.5 SGS S.A. (Switzerland) Recent Developments
5.9 Texcell, Inc. (France)
5.9.1 Texcell, Inc. (France) Profile
5.9.2 Texcell, Inc. (France) Main Business
5.9.3 Texcell, Inc. (France) Viral Detection Products, Services and Solutions
5.9.4 Texcell, Inc. (France) Viral Detection Revenue (US$ Million) & (2018-2023)
5.9.5 Texcell, Inc. (France) Recent Developments
5.10 WuXi PharmaTech (Cayman) Inc. (China)
5.10.1 WuXi PharmaTech (Cayman) Inc. (China) Profile
5.10.2 WuXi PharmaTech (Cayman) Inc. (China) Main Business
5.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Products, Services and Solutions
5.10.4 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Revenue (US$ Million) & (2018-2023)
5.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Developments
6 North America
6.1 North America Viral Detection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Detection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Detection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Detection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Detection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Detection Market Dynamics
11.1 Viral Detection Industry Trends
11.2 Viral Detection Market Drivers
11.3 Viral Detection Market Challenges
11.4 Viral Detection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
